- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: Fungemia.
Displaying page 1 of 1.
EudraCT Number: 2010-020814-27 | Sponsor Protocol Number: 65091-06093 | Start Date*: 2012-05-10 | |||||||||||
Sponsor Name:EORTC | |||||||||||||
Full Title: Empirical versus pre-emptive (diagnostic-driven) antifungal therapy of patients treated for haematological malignancies or receiving an allogeneic stem cell transplant. A therapeutic open label pha... | |||||||||||||
Medical condition: Invasive fungal infection in patients with hematological malignancies. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) NL (Completed) BE (Completed) CZ (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003698-13 | Sponsor Protocol Number: ABR-54775 | Start Date*: 2015-12-30 | |||||||||||
Sponsor Name:Radboudumc | |||||||||||||
Full Title: Neuroinflammation in sepsis encephalopathy: the NINEVEH-study | |||||||||||||
Medical condition: sepsis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003708-22 | Sponsor Protocol Number: E2015-PK-USI-BMR-COLISTIN | Start Date*: 2015-10-23 | |||||||||||
Sponsor Name:Hospital Erasme | |||||||||||||
Full Title: Colistin use in critically ill patients: pharmacokinetic population and pharmacodynamic studies, tolerance profil and risk of selection of resistance | |||||||||||||
Medical condition: Patients in intensive care unit suffering of infection by multi-drug resistance bacteria treated by colistin | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001573-10 | Sponsor Protocol Number: E2011HDinfection | Start Date*: 2012-01-24 | ||||||||||||||||
Sponsor Name:Hôpital Erasme | ||||||||||||||||||
Full Title: optimization of doses of broad spectrum B-lactames (ceftazidim and meropenem) and vancomycin in septic patient traeted with chronic hemodialysis. | ||||||||||||||||||
Medical condition: hemodialysis oligoanuria sepsis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-001809-14 | Sponsor Protocol Number: E2015-PK-HD-PTAZ-MERO-CTAZ | Start Date*: 2015-06-24 | ||||||||||||||||
Sponsor Name:Hopital Erasme | ||||||||||||||||||
Full Title: Beta-Lactams (ceftazidime, piperacilline-tazobactam, meropenem) dosing scheme validation in septic hemodialysed patient | ||||||||||||||||||
Medical condition: sepsis in patient undergoing dialysis for renal insufficiency | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-003243-34 | Sponsor Protocol Number: C2661002/D3720C00009 | Start Date*: 2015-02-02 | |||||||||||
Sponsor Name:Pfizer Inc. | |||||||||||||
Full Title: Open-label, Multicentre Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Ceftaroline in Neonates and Young Infants with Late-Onset Sepsis | |||||||||||||
Medical condition: Late-onset Sepsis | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) ES (Completed) IT (Completed) LT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000196-32 | Sponsor Protocol Number: METABOLICRESUS | Start Date*: 2018-11-06 | |||||||||||
Sponsor Name:HU DE GIRONA DR JOSEP TRUETA | |||||||||||||
Full Title: PILOT STUDY ON THE USE OF HYDROCORTISONE, VITAMIN C AND THYAMINE IN PATIENT WITH SEPSIS AND SEPTIC SHOCK. | |||||||||||||
Medical condition: sepsis and septic shock | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000755-13 | Sponsor Protocol Number: DACLEAN | Start Date*: 2020-03-31 | |||||||||||
Sponsor Name:CHU de Poitiers | |||||||||||||
Full Title: ESTIMATION OF THE INCIDENCE OF COLONIZATION OF PERIPHERAL VENOUS CATHETERS AFTER SKIN DISINFECTION WITH 0.5% SODIUM HYPOCHLORITE, PRECEDED OR NOT BY AN APPLICATION OF 70% ETHANOL: PILOT, MONOCENTRI... | |||||||||||||
Medical condition: Bacterial colonization of peripheral venous catheters | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001754-21 | Sponsor Protocol Number: 2020-23 | Start Date*: 2020-05-19 |
Sponsor Name:Assistance Publique Hôpitaux de Marseille | ||
Full Title: An open prospective randomized therapeutic trial using ANAKINRA or TOCILIZUMAB alone or in combination with RUXOLITINIB in severe stage 2b and 3 COVID-19 disease | ||
Medical condition: COVID-19-associated disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002112-99 | Sponsor Protocol Number: F1K-MC-EVDK | Start Date*: 2006-09-26 | |||||||||||
Sponsor Name:Eli Lilly & Company Limited | |||||||||||||
Full Title: A Phase 2 Study to Evaluate Dose and Duration of Treatment of Drotrecogin Alfa (Activated) Using Serial Measurements of Protein C in Patients with Severe Sepsis and Multiple Organ Dysfunction | |||||||||||||
Medical condition: severe sepsis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) SE (Prematurely Ended) FR (Completed) FI (Completed) IT (Completed) GB (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
